JP2005511608A5 - - Google Patents

Download PDF

Info

Publication number
JP2005511608A5
JP2005511608A5 JP2003542177A JP2003542177A JP2005511608A5 JP 2005511608 A5 JP2005511608 A5 JP 2005511608A5 JP 2003542177 A JP2003542177 A JP 2003542177A JP 2003542177 A JP2003542177 A JP 2003542177A JP 2005511608 A5 JP2005511608 A5 JP 2005511608A5
Authority
JP
Japan
Prior art keywords
alkyl
cycloalkyl
hydrogen
aryl
alkylamino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003542177A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005511608A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2002/012164 external-priority patent/WO2003040131A1/en
Publication of JP2005511608A publication Critical patent/JP2005511608A/ja
Publication of JP2005511608A5 publication Critical patent/JP2005511608A5/ja
Pending legal-status Critical Current

Links

JP2003542177A 2001-11-07 2002-10-31 アミノピリミジン類及び−ピリジン類 Pending JP2005511608A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33831201P 2001-11-07 2001-11-07
PCT/EP2002/012164 WO2003040131A1 (en) 2001-11-07 2002-10-31 Aminopyrimidines and pyridines

Publications (2)

Publication Number Publication Date
JP2005511608A JP2005511608A (ja) 2005-04-28
JP2005511608A5 true JP2005511608A5 (https=) 2006-01-05

Family

ID=23324288

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003542177A Pending JP2005511608A (ja) 2001-11-07 2002-10-31 アミノピリミジン類及び−ピリジン類

Country Status (12)

Country Link
US (2) US6846828B2 (https=)
EP (1) EP1444223A1 (https=)
JP (1) JP2005511608A (https=)
KR (1) KR20050042062A (https=)
CN (1) CN1582284A (https=)
AR (1) AR039554A1 (https=)
BR (1) BR0213899A (https=)
CA (1) CA2465711A1 (https=)
MX (1) MXPA04004166A (https=)
PL (1) PL370480A1 (https=)
RU (1) RU2308455C2 (https=)
WO (1) WO2003040131A1 (https=)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0021726D0 (en) * 2000-09-05 2000-10-18 Astrazeneca Ab Chemical compounds
GB0205690D0 (en) * 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
US7442697B2 (en) * 2002-03-09 2008-10-28 Astrazeneca Ab 4-imidazolyl substituted pyrimidine derivatives with CDK inhibitory activity
GB0205693D0 (en) 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
GB0205688D0 (en) * 2002-03-09 2002-04-24 Astrazeneca Ab Chemical compounds
JP2006512313A (ja) 2002-10-31 2006-04-13 アムジェン インコーポレイテッド 抗炎症剤
CN100441569C (zh) * 2003-02-24 2008-12-10 横滨橡胶株式会社 化合物和使用了该化合物的组合物
GB0311274D0 (en) * 2003-05-16 2003-06-18 Astrazeneca Ab Chemical compounds
GB0311276D0 (en) * 2003-05-16 2003-06-18 Astrazeneca Ab Chemical compounds
WO2005035527A1 (en) * 2003-10-14 2005-04-21 Pharmacia Corporation Substituted pyrazinone compounds for the treatment of inflammation
TW200533357A (en) * 2004-01-08 2005-10-16 Millennium Pharm Inc 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases
TW200528101A (en) * 2004-02-03 2005-09-01 Astrazeneca Ab Chemical compounds
KR101280095B1 (ko) * 2004-08-28 2013-09-09 아스트라제네카 아베 케모킨 수용체 조절제로서의 피리미딘 술폰아미드 유도체
NZ555474A (en) * 2004-12-17 2010-10-29 Astrazeneca Ab 4-(4-(imidazol-4-yl) pyrimidin-2-ylamino) benzamides as CDK inhibitors
GB0514017D0 (en) * 2005-07-07 2005-08-17 Ionix Pharmaceuticals Ltd Chemical compounds
MX2008001428A (es) * 2005-07-30 2008-04-04 Astrazeneca Ab Compuestos de imidazolil-pirimidina para uso en el tratamiento de trastornos proliferativos.
WO2007036732A1 (en) * 2005-09-30 2007-04-05 Astrazeneca Ab Imidazo [1,2-a] pyridine having anti-cell-proliferation activity
AR058277A1 (es) * 2005-12-09 2008-01-30 Solvay Pharm Gmbh N- sulfamoil - piperidin - amidas, composiciones farmaceuticas que las comprenden y procedimiento para su preparacion
TW200811169A (en) * 2006-05-26 2008-03-01 Astrazeneca Ab Chemical compounds
US20110117121A1 (en) * 2006-10-27 2011-05-19 James Dao Compositions for treatment and inhibition of pain
JP2013512674A (ja) * 2009-12-02 2013-04-18 アクセルロン ファーマ, インコーポレイテッド Fc融合タンパク質の血清半減期を増加させるための組成物および方法
US8754114B2 (en) 2010-12-22 2014-06-17 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
EP2718328A4 (en) 2011-06-08 2014-12-24 Acceleron Pharma Inc COMPOSITIONS AND METHODS FOR INCREASING THE HALF TIME OF SERUM
ES2704744T3 (es) 2012-06-13 2019-03-19 Incyte Holdings Corp Compuestos tricíclicos sustituidos como inhibidores de FGFR
US9388185B2 (en) 2012-08-10 2016-07-12 Incyte Holdings Corporation Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
EA035095B1 (ru) 2013-04-19 2020-04-27 Инсайт Холдингс Корпорейшн Бициклические гетероциклы в качестве ингибиторов fgfr
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MX373169B (es) 2015-02-20 2020-04-24 Incyte Holdings Corp Heterociclos bicíclicos como inhibidores de receptores del factor de crecimiento fibroblástico (fgfr).
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
WO2016134294A1 (en) 2015-02-20 2016-08-25 Incyte Corporation Bicyclic heterocycles as fgfr4 inhibitors
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
JP7271540B2 (ja) * 2017-11-17 2023-05-11 へパジーン セラピューティクス (エイチケイ) リミテッド Ask1阻害剤としての尿素誘導体
MA52493A (fr) 2018-05-04 2021-03-10 Incyte Corp Sels d'un inhibiteur de fgfr
CR20200590A (es) 2018-05-04 2021-04-26 Incyte Corp Formas sólidas de un inhibidor de fgfr y procesos para prepararlas
KR102441327B1 (ko) * 2018-05-18 2022-09-07 주식회사유한양행 다이아미노피리미딘 유도체 또는 이의 산부가염의 신규의 제조방법
CN109336800B (zh) * 2018-09-17 2022-11-29 江西中医药大学 一种dhnb缩苯基氨基硫脲化合物及其制备方法和用途
WO2020185532A1 (en) 2019-03-08 2020-09-17 Incyte Corporation Methods of treating cancer with an fgfr inhibitor
WO2021007269A1 (en) 2019-07-09 2021-01-14 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
WO2021067374A1 (en) 2019-10-01 2021-04-08 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
TWI891666B (zh) 2019-10-14 2025-08-01 美商英塞特公司 作為fgfr抑制劑之雙環雜環
WO2021076728A1 (en) 2019-10-16 2021-04-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
BR112022010664A2 (pt) 2019-12-04 2022-08-16 Incyte Corp Derivados de um inibidor de fgfr
EP4069696A1 (en) 2019-12-04 2022-10-12 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
WO2021146424A1 (en) 2020-01-15 2021-07-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
TW202304459A (zh) 2021-04-12 2023-02-01 美商英塞特公司 包含fgfr抑制劑及nectin-4靶向劑之組合療法
WO2022261159A1 (en) 2021-06-09 2022-12-15 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
EP4352059A1 (en) 2021-06-09 2024-04-17 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
CN115919864B (zh) * 2022-12-02 2024-09-03 中南大学湘雅三医院 唑嘧啶胺类化合物在用于制备治疗ibd药物中的应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2095240A (en) * 1981-03-05 1982-09-29 Fujisawa Pharmaceutical Co Dihydropyrimidine derivatives, processes for preparation thereof and pharmaceutical composition comprising the same
EP0457717B1 (de) 1990-05-16 1995-10-25 Sulzer Chemtech AG Verfahren zur gerichteten fraktionierten Kristallisation
EP0457727A1 (de) * 1990-05-17 1991-11-21 Ciba-Geigy Ag Schädlingsbekämpfungsmittel
IL106786A (en) * 1992-09-10 1997-02-18 Basf Ag Substituted pyridine derivatives and fungicidal compositions containing them
RU2153494C2 (ru) * 1993-10-12 2000-07-27 Дзе Дюпон Мерк Фармасьютикал Компани 1-n-алкил-n-арилпиримидинамины, способ лечения заболеваний, фармацевтическая композиция
ES2250363T3 (es) * 2000-02-02 2006-04-16 Dorian Bevec Guanilhidrazonas aromaticas farmaceuticamente activas.
CA2427284A1 (en) 2000-10-26 2002-05-30 Tularik Inc. Antiinflammation agents

Similar Documents

Publication Publication Date Title
JP2005511608A5 (https=)
RU2004117545A (ru) Аминопиримидины и пиридины
JP6193922B2 (ja) ハロアルキルヘテロアリールベンズアミド化合物
US6924302B2 (en) Substituted triazole diamine derivatives as kinase inhibitors
JP2568315B2 (ja) 縮合環アリール置換イミダゾール
JP2550442B2 (ja) 置換イミダゾール
JP2001526230A (ja) ヘテロアリール置換イミダゾール化合物、その医薬組成物および使用
DE08851028T1 (de) Verwendung von crth2-antagonisten-verbindungen
RU2007146798A (ru) ПРОИЗВОДНЫЕ 4-(2-АМИНО-1-ГИДРОКСИЭТИЛ)ФЕНОЛА КАК АГОНИСТЫ β2 АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА
JP2007504160A5 (https=)
EA016887B1 (ru) ЗАМЕЩЁННЫЕ ФЕНОКСИАМИНОТИАЗОЛОНЫ В КАЧЕСТВЕ МОДУЛЯТОРОВ РОДСТВЕННОГО ЭСТРОГЕНОВОМУ РЕЦЕПТОРУ РЕЦЕПТОРА-α
JP2005526028A5 (https=)
JP2002505690A (ja) 新規なアリールオキシピリミジン置換イミダゾール化合物
EP2107054A1 (en) Antiproliferative compounds and therapeutic uses thereof
JP2002528506A (ja) ピリジン−4−イルまたはピリミジン−4−イル置換ピラジン
EA029718B1 (ru) Бифтордиоксалан-аминобензимидазольные ингибиторы киназы для лечения рака, аутоиммунного воспаления и нарушений цнс
JP2001518507A (ja) 新規シクロアルケニル置換化合物
AU2005221131A1 (en) Ion channel modulators
CA2617991A1 (en) N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
CA2557650A1 (en) Ion channel modulators
AU2005231123A1 (en) Ion channel modulators
JP2012528843A5 (https=)
JPWO2019213570A5 (https=)
CA2558217A1 (en) Ion channel modulators
JP2008517907A5 (https=)